Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 327.40M
March 31, 2026 291.08M
December 31, 2025 277.40M
September 30, 2025 223.85M
June 30, 2025 204.72M
March 31, 2025 201.34M
December 31, 2024 178.88M
September 30, 2024 216.98M
June 30, 2024 206.91M
March 31, 2024 245.56M
December 31, 2023 204.62M
September 30, 2023 188.41M
June 30, 2023 64.97M
March 31, 2023 -133.74M
December 31, 2022 -157.20M
September 30, 2022 -159.30M
June 30, 2022 16.28M
March 31, 2022 334.36M
December 31, 2021 453.99M
September 30, 2021 755.30M
June 30, 2021 714.23M
March 31, 2021 581.14M
December 31, 2020 543.92M
September 30, 2020 203.55M
June 30, 2020 184.93M
Date Value
March 31, 2020 210.99M
December 31, 2019 183.05M
September 30, 2019 139.32M
June 30, 2019 116.80M
March 31, 2019 58.03M
December 31, 2018 0.9395M
September 30, 2018 24.72M
June 30, 2018 51.46M
March 31, 2018 105.01M
December 31, 2017 165.27M
September 30, 2017 201.46M
June 30, 2017 199.50M
March 31, 2017 231.84M
December 31, 2016 213.69M
September 30, 2016 152.67M
June 30, 2016 164.95M
March 31, 2016 124.55M
December 31, 2015 42.73M
September 30, 2015 137.31M
June 30, 2015 130.48M
March 31, 2015 136.65M
December 31, 2014 241.40M
September 30, 2014 120.03M
June 30, 2014 142.02M
March 31, 2014 136.58M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Ottobock SE & Co. KGaA --
Abbott Laboratories 9.905B
AngioDynamics, Inc. 3.089M
Alphatec Holdings, Inc. 56.52M
AtriCure, Inc. 64.94M